drugset / Trial / NCT01798121

Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)

NCT01798121

Phase 2 Unknown 90 enrolled JHP Pharmaceuticals LLC Syneos Health · collab
RandomizedSingle-groupDouble-blind

Summary

A study to determine bioequivalence of PPD material versus Reference Standard.

Timeline

Start
2013-02
Primary completion
2013-03
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tuberculin PPD Standard. Protein / enzyme biologic
Subject tuberculin Diagnostic / imaging agent

Indications